SLC5A2 and diabetes mellitus: Due to the pathophysiological molecular parallels in diabetes as well as in viral-infected cells, this narrative literature review discusses the potential role of sodium–glucose cotransporter 2 (SGLT2) inhibition therapy in the context of LCS.